Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.32B | 6.61B | 6.32B | 5.86B | 7.47B | 5.13B |
Gross Profit | 2.66B | 2.50B | 2.66B | 2.43B | 4.17B | 2.27B |
EBITDA | 2.89B | 3.97B | 3.30B | 2.85B | 4.63B | 2.56B |
Net Income | 835.10M | 829.40M | 835.10M | 1.53B | 2.23B | 886.60M |
Balance Sheet | ||||||
Total Assets | 19.65B | 22.63B | 19.65B | 18.24B | 17.28B | 16.60B |
Cash, Cash Equivalents and Short-Term Investments | 3.38B | 4.32B | 3.38B | 2.39B | 3.71B | 3.67B |
Total Debt | 4.08B | 5.35B | 4.08B | 3.27B | 3.17B | 3.75B |
Total Liabilities | 7.60B | 9.68B | 7.60B | 6.59B | 6.25B | 6.52B |
Stockholders Equity | 8.95B | 9.46B | 8.95B | 8.63B | 8.35B | 7.75B |
Cash Flow | ||||||
Free Cash Flow | 203.80M | -129.30M | 203.80M | -2.30M | 1.89B | 751.30M |
Operating Cash Flow | 2.33B | 2.29B | 2.33B | 1.88B | 3.67B | 2.06B |
Investing Cash Flow | -2.09B | -2.08B | -2.09B | -477.50M | -2.20B | -2.19B |
Financing Cash Flow | -402.00M | 1.35B | -402.00M | -1.33B | -1.95B | 717.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $10.62B | 96.26 | 3.70% | 1.39% | 25.76% | -41.10% | |
77 Outperform | £279.71M | 7.11 | 13.74% | 6.28% | 6.77% | 32.64% | |
74 Outperform | £650.31M | 12.85 | 11.38% | 0.97% | 17.22% | 97.69% | |
70 Neutral | £36.38B | ― | -3.81% | 1.82% | 3.11% | -137.83% | |
66 Neutral | £18.89B | ― | 7.09% | ― | ― | ||
61 Neutral | $24.43B | ― | -13.39% | 0.01% | -13.16% | -1091.44% | |
57 Neutral | £2.72B | 4.85 | -9.97% | 3.91% | -1.19% | -6.71% |